Skip to content
September 24, 2019

First aiForward project commences

“I have been thinking about these vessels, a lot. I am excited to finally be able to see them in a tissue context.”
Reidunn Edelmann, an MD currently doing postdoctoral research at the University of Bergen at the Centre for Cancer Biomarkers (CCBIO) in Norway, is one of the first successful aiForward applicants. Driven by a passion for clinical research, Reidunn completed his PhD in cell biology after her medical studies and is currently focusing on studying biomarkers and vessel characteristics in cancer. She is interested in changing paradigms over how biomarkers and vessels are studied, from simple “very much just focused on one marker,” as she explains, “to thinking about the wider, more functional picture.”
Read the rest on the aiForward website.